Kmph Stock Forecast Zacks. $303,000,000 % of market cap. (nasdaq:kmph) will announce $12.10 million in sales for the current fiscal quarter, zacks investment research reports.
(see the last biotech stock roundup here: 16, 2018 when the stock price was at 12.92$.
5 Day Chart For NYSEHGV Insider Trading Chart Vacation
47 rows the average price target is $12.00, with a high forecast of $12.00 and a low forecast of. A rank of 38 means that 62% of stocks.
Kmph Stock Forecast Zacks
Feb 5, 2021 8:30pm est.Get the latest kempharm, inc.In the latest trading session, baidu inc.In the medium term (3months), mark’s stock price should outperform the market by.
Investorsobserver gives salarius pharmaceuticals inc (slrx) an overall rank of 38, which is below average.Kempharm (nasdaq:kmph) was upgraded by zacks investment research from a “hold” rating to a “buy” rating in a research report issued on thursday, zacks.com reports.Kempharm last released its earnings results on may 13th, 2021.Kempharm’s stock was trading at $0.2452 on march 11th, 2020 when coronavirus reached pandemic status according to the world health organization (who).
Kmph analyst rating is buy.Kmph need to pay close attention to the stock based on moves in the options market lately.Kmph need to pay close attention to the stock based on moves in the options market lately.Kmph, which carries a zacks rank #1 (strong.
Mar 17, 2021 8:30am edt.Mark stock forecast our latest prediction for remark holdings inc’s stock price was made on the jan.Number of etfs holding kmph:Over the last 60 days, no analysts have increased their earnings estimates for the current quarter, while one analyst has revised the estimate downward.
Over the last 60 days, the zacks consensus estimate for the current quarter has narrowed from a loss of 46 cents per share to a loss of 44 cents.Over the past six months, shares of alexion have surged 32.88%.Price target in 14 days:Regulatory updates from regn, incy, & other updates)
Salarius pharmaceuticals inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock’s chart.Since then, kmph stock has increased by 5,711.6% and is now trading at $14.25.That is because the mar 19, 2021 $10.00 call had some of the highest implied volatility of all equity options today.That means the average analyst price target for kmph stock is $19.00.
The brokerage presently has a $0.25 target price on the specialty pharmaceutical company’s stock.The business earned $12.12 million during the quarter, compared to analyst estimates of.The low price target for kmph is $10.00, while the high price target is $28.00.The nasdaq biotechnology index lost 6.51% in the last five trading sessions.
The prediction is based on 2 analyst estimates.The specialty pharmaceutical company reported ($1.61) earnings per share (eps) for the quarter, missing analysts’ consensus estimates of ($0.17) by $1.44.The trader’s cheat sheet is a list of 44 commonly used technical indicators with the price projection for the next trading day that will cause each of the signals to be triggered.The trader’s cheat sheet is updated for the next market ses
sion upon receiving a settlement or end of day record for the current market session.
This change lagged the s&p 500’s daily gain of.Total market value held by etfs:Two analysts have made estimates for kempharm’s earnings.Wall street analysts expect that kempharm, inc.
What is kmph stock forecast (i.e., prediction)?
